Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.860
-0.120 (-6.06%)
At close: Dec 5, 2025, 4:00 PM EST
1.920
+0.060 (3.23%)
After-hours: Dec 5, 2025, 7:31 PM EST
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $112.67 million as of December 5, 2025. Its market cap has decreased by -21.54% in one year.
Market Cap
112.67M
Enterprise Value
7.45M
1-Year Change
-21.54%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $112.67M, a decrease of -81.78%. That is a compound annual growth rate of -31.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 112.67M | 9.03% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |